Novartis NGSP Global Scholars Program – 2023 Pre-Proposal Deadline
OnlineNovartis NGSP Scholars will receive up to $1M funding over 3 years along with drug-hunting expertise from NIBR scientific collaborators.
Loading view.
Medical, Biomedical & Biodefense: Support to the Warfighter Symposium
North Carolina Biotechnology Center 15 TW Alexander Drive, Durham, NC, United StatesThe symposium will foster awareness and dialogue among government (DoD), academia, and industry stakeholders in support of our warfighters.
$175
Grant opportunity: Emily’s Entourage’s Gene-based Therapy Initiative for Cystic Fibrosis
OnlineGrant opportunity for promising therapies and drug-delivery mechanisms to accelerate the development of gene-based therapies for people with cystic fibrosis.
Mochida Open Innovation Research (MOIRe) program applications
OnlineMOIRe is Mochida Pharmaceutical's open innovation program for drug discovery research based on proposals from academic researchers.
Translational Research Grant: NC Biotech Center
OnlineThe Translational Research Grant program from NCBC supports commercial development of university research with up to $110K awards. Due 8/23.
NIH and NSF: SBIR/STTR Phase 1 Proposal Strategy Session by SBTDC
OnlineSBTDC hosts an intensive session to help educate and prepare you for a Phase 1 SBIR / STTR proposal submission to NIH and NSF in 2024.
NC Biotechnology Center info session for Duke
Wilkinson Auditorium 132Join NCBC for an information session and lunch discussing funding opportunities in the life sciences specifically for Duke researchers.
The Journey of the Molecule: Sustainability in Action
BioLabs NC 701 W Main St., Durham, United StatesAn event discussing sustainable innovation, co-hosted by the RTP chapter of Nucleate and industry partner MilliporeSigma.
NATA visit with Duke researchers
CIEMAS 2240 101 Science Dr., Durham, NC, United StatesThe Nucleic Acid Therapy Accelerator (NATA) is a UK, not-for-profit research organization established to accelerate the clinical development of nucleic acid therapies.